Laparoscopic gastrectomy vs open gastrectomy
It is very uncertain whether laparoscopic gastrectomy changes long‐term recurrence (maximal compared with open gastrectomy (very low certainty).
- HR 0.95 [0.7, 1.3]4 studies · 162 participantsVery low
It is very uncertain whether laparoscopic gastrectomy changes long‐term recurrence (maximal compared with open gastrectomy (very low certainty).
It is very uncertain whether laparoscopic changes long‐term mortality compared with open transhiatal oesophagectomy (very low certainty).
It is very uncertain whether laparoscopic changes long‐term recurrence compared with open transhiatal oesophagectomy (very low certainty).
It is very uncertain whether laparoscopic distal pancreatectomy changes long‐term mortality compared with open distal pancreatectomy (very low certainty).
It is very uncertain whether non‐surgical changes long‐term recurrence (binary outcome) Local recurrence, surgical… compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
Non‐surgical showed no clear difference in long‐term recurrence (time‐to‐event outcome) Local recurrence,… compared with surgical treatment of oesophageal cancer (secondary outcomes) (low certainty).
Non‐surgical showed no clear difference in long‐term mortality (binary outcome) All‐cause mortality for the… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
It is very uncertain whether duodenum‐preserving pancreatic resection changes long‐term mortality compared with pancreaticoduodenectomy (very low certainty).
It is very uncertain whether summary of findings for the main comparison. Implantable loop recorder changes all‐cause long‐term mortality compared with conventional diagnostic workup (very low certainty).
Protease‐modulating matrix dressing regimen showed no clear difference in proportion of participants healed ‐ long term (over 24 weeks) compared with any other dressing regimen (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether fractional laser changes participant‐reported scar improvement (long‐term) N of participants… compared with combined chemical peeling plus needling (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether chemical peeling changes participant‐reported scar improvement (long‐term) N of participants… compared with combined chemical peeling plus any active intervention (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.